tm
Seeing Is Believing
tm
Seeing Is Believing
ZIOPHARM Oncology's activity chart (see below) currently has 6 price targets and 8 ratings on display.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 847.67 days.
Most recent stock forecast was given by DAVID NOVAK from RAYMOND JAMES on 10-Aug-2021. First documented stock forecast 16-Jan-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Mar-2020
$3
$-9.38 (-75.77%)
5 years 1 months 22 days ago
(10-Aug-2021)
0/2 (0%)
$-25.8 (-89.58%)
Buy Since 10-Aug-2021
$7
$-5.38 (-43.46%)
5 years 1 months 22 days ago
(10-Aug-2021)
0/1 (0%)
$-21.8 (-75.69%)
Buy
$5
$4.17 (502.41%)
$7
5 years 6 months 20 days ago
(12-Mar-2021)
0/2 (0%)
$2.17 (63.99%)
Buy Since 16-Jan-2015
11 years 4 months 25 days ago
(07-May-2015)
3/3 (100%)
$-111.6 (-88.15%)
2543
What is ZIOP (ZIOPHARM Oncology) average time for price targets to be met?
Which analyst most recently updated their price target on ZIOP (ZIOPHARM Oncology)?
Which analyst has the most public recommendations on ZIOP (ZIOPHARM Oncology)?
Which analyst is the currently most bullish on ZIOP (ZIOPHARM Oncology)?
Which analyst is the currently most reserved on ZIOP (ZIOPHARM Oncology)?
